Joint-replacement patients these days are younger and more active than ever before. And while implant makers are working to build longer-wearing knees and hips, many patients may not be able to resume high-impact activities.
The FDA said it will require some painkiller manufacturers to produce new educational tools in an effort to quell prescription-drug abuse.
Subscriber Content Read Preview
Johnson & Johnson's earnings fell 23%, hurt by litigation and recall-related charges, but the health-care giant's revenue received a boost from a weaker dollar and J&J; raised its full-year earnings forecast.
The first update in nearly 30 years to U.S. guidelines for the diagnosis of Alzheimer's disease expands the definition to include patients with earlier stage symptoms.
Researchers are studying what happens to astronauts' hearts in space to help patients back on Earth.
Researchers have developed a new vaccine to desensitize people with a cat allergy that is faster and safer than traditional immunotherapies.
That adorable crib may be a health hazard. Fluffy bumpers, pillows and blankets and a menagerie of stuffed animals all pose a suffocation risk to babies less than 12 months old.
Snoring and waking up at night are common nighttime annoyances, but for many, they are signs of a major health problem: sleep apnea. A number of companies are marketing nasal devices to treat the disorder.
Subscriber Content Read Preview
U.S. drug makers Pfizer and Eli Lilly are flying against some strong headwinds, including patent expirations and government imposed price cuts. But a weaker U.S. dollar is giving a lift to their first-quarter sales figures.
Subscriber Content Read Preview
A trial to determine whether AIDS drugs taken by mouth can ward off HIV infection in women has been stopped early, a setback that surprised researchers after a string of successes in preventing transmission of the disease.
The use of a drug for the rare blood disorder hemophilia has soared in hospitals in the U.S. in the last decade, but nearly all of the growth has come from treatment of medical conditions for which the medicine has little proven benefit, researchers said.
Subscriber Content Read Preview
Community Health Systems converted its roughly $3.3 billion bid for Tenet Health to all-cash, the latest salvo in the hospital operator's hostile pursuit of its smaller rival.
Subscriber Content Read Preview
A potential $20 billion medical-device deal with Synthes would be Johnson & Johnson's biggest-ever acquisition and reinvigorate its struggling device business.
Subscriber Content Read Preview
Johnson & Johnson is in talks to buy U.S.-Swiss medical-equipment maker Synthes in a deal that could be valued at around $20 billion. The deal would rank as one of the biggest health-care takeovers in recent years.
An Illinois drug maker plans next week to resume shipments of a key leukemia drug, helping to alleviate a life-threatening shortage of the drug, although it won't immediately fix the problem.
Subscriber Content Read Preview
The New York Inspector General's office is investigating the leak of a state audit of a $1 billion home-care company, after a Journal article reported that state Medicaid auditors were investigating whether Visiting Nurse Service of New York over-billed the Medicaid program.
The Oregon Medical Board forced a neurosurgeon who performed multiple spinal fusions on the same patients to seek prior approval before doing any more surgeries, in a temporary step pending a full investigation.
Subscriber Content Read Preview
Four years after launching the nonprescription diet pill Alli with much fanfare and a heavy marketing budget, U.K. drug maker GlaxoSmithKline said it plans to sell the drug along with a clutch of other over-the-counter brands.
Subscriber Content Read Preview
President Barack Obama outlined a plan to cut $480 billion by 2023 from the U.S. government's health-care programs for the elderly and poor, drawing a sharp line of disagreement with House Republican leaders over how to rein in the burgeoning costs of medical care.
A shortage of a key leukemia drug that started last year has worsened, causing many major cancer centers such as the Johns Hopkins Hospital to start rationing the drug and others to turn away patients from community hospitals that have run out of the medication.
A new multiple-sclerosis study questions a theory about a potential cause for the autoimmune disease that had been embraced by patients around the world, who had turned to risky surgeries to unblock neck veins when drug treatments didn't work for them.
A Portland, Ore., neurosurgeon who performed multiple spinal fusions on the same patients lost his operating privileges at the hospital where he did many of his surgeries and is under investigation by the Oregon Medical Board.
The online atlas documents the interplay between brain structure and biochemistry, charting genes at work throughout the human brain.
Subscriber Content Read Preview
An FDA advisory panel backed the use of two cancer drugs from Novartis and Pfizer to treat a rare type of pancreatic cancer.
Subscriber Content Read Preview
A study found that more than one-fourth of rheumatoid arthritis patients developed resistance to Abbott's anti-inflammatory drug Humira.
As more young people are diagnosed with osteoarthritis, doctors are recommending physical activity to help joints over traditional advice to take it easy.
Recent studies suggest ancient viruses, which litter the human genome but were believed to lie dormant, may play a role in modern diseases like Hodgkin's lymphoma and multiple sclerosis.
Subscriber Content Read Preview
Novartis is discontinuing the development of its drug Tasigna as initial therapy for patients with a rare form of stomach cancer because it is unlikely the drug will work better than Gleevec, the current standard of care.
Generic drugs now make up 78% of all prescriptions dispensed, according to the IMS Institute for Healthcare Informatics.
J&J;'s first-quarter earnings results exceeded analysts' expectations and in doing so, helped lead the market higher this morning.
Also: defining Alzheimer's disease; living organ donors and insurance coverage; developing countries and flu pandemics.
High-deductible plans put "a greater burden on families to sort out ... what is necessary and what is not necessary care."
After losing her arm in a shark attack, Bethany Hamilton stays competitive on the surfing circuit with a workout designed to improve core strength and balance.
How can the nation offer more people quality health care at a price the country can afford? The answer is in innovation.
Intensive-care units are getting a much-needed makeover. At Montefiore Medical Center in New York, the benefits are dramatic.
Mobile-health technology is booming. In the words of one doctor, smartphone apps, wireless sensors and other innovative tools hold "transformative potential."
Accountable-care organizations were promoted in the health-care law. But it's hard to know exactly what they are.
The city is one of 50 communities in a federal grant program designed to see what approaches work best at keeping people healthier through preventive measures.
New practices are dramatically reducing one of the most devastating medical problems: birth injuries and deaths
Journal articles on nation-wide flu vaccination in 1976:
In a culture where it's easy to fire off a snippy email or text, most of us have a hard time honestly expressing anger face to face.
If the British experience is any indication, generic drugs and expert commissions will do little to lower costs, says Theodore Dalrymple.
Those bowls of candy build esprit de corps in the office -- or do they? Apparently, something sweet can also be divisive.
Matt Ridley on a discovery that may help find a medication against the disease.
Family therapists, marriage counselors and life coaches increasingly recognize that personality assessments can lead clients not only to greater self-insight but also to improved relationships.
Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.
The latest news and analysis delivered to your in-box. Check the boxes below to sign up.
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)